Quest Diagnostics Inc. (DGX) is a publicly traded Healthcare sector company. As of May 21, 2026, DGX trades at $193.75 with a market cap of $21.01B and a P/E ratio of 21.18. DGX moved +2.02% today. Year to date, DGX is +11.68%; over the trailing twelve months it is +8.70%. Its 52-week range spans $146.17 to $213.50. Analyst consensus is buy with an average price target of $220.50. Rallies surfaces DGX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Quest Diagnostics Inc. (DGX) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. DGX moved +2.02% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $193.75 |
| Market Cap | $21.01B |
| P/E Ratio | 21.18 |
| EPS | $9.17 |
| Dividend Yield | 0.86% |
| 52-Week High | $213.50 |
| 52-Week Low | $146.17 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $11.28B |
| Net Income | $1.07B |
| Gross Margin | 33.20% |
9 analysts cover DGX: 0 strong buy, 4 buy, 5 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $220.50.